When you hear immunotherapy, a treatment that trains your immune system to recognize and attack disease. Also known as biological therapy, it’s not just for cancer—it’s changing how we treat autoimmune disorders, chronic infections, and even some allergies. Unlike chemo or radiation that hit everything in their path, immunotherapy works like a smart missile: it finds the bad guys and leaves the good stuff alone.
It works because your immune system already knows how to kill threats—but sometimes, diseases like cancer learn to hide. checkpoint inhibitors, a type of immunotherapy drug that removes the brakes on immune cells are one of the biggest breakthroughs. Drugs like Keytruda and Opdivo block signals cancer uses to trick your body into ignoring it. Once those brakes are off, your T-cells go to work. For some people with melanoma or lung cancer, this means years of remission where nothing else worked.
But it’s not magic. immunosuppression, the intentional calming of the immune system is the flip side of the coin. After a liver transplant, for example, patients take drugs to stop their immune system from attacking the new organ. That’s immunosuppression. In autoimmune diseases like MS, it’s used to stop the immune system from attacking nerves. But in cancer, we want the opposite: we want to wake it up. The same tools can save lives or endanger them—depending on the goal.
Immunotherapy isn’t for everyone. Some patients see amazing results. Others don’t respond at all. And side effects? They’re different from chemo. Instead of nausea or hair loss, you might get inflammation in the lungs, liver, or even the thyroid. That’s because your immune system, once unleashed, can start attacking healthy tissue. That’s why monitoring is critical—and why knowing the difference between a side effect and a true immune reaction matters.
What you’ll find in these articles isn’t just theory. It’s real-world stuff: how immunotherapy connects to liver transplants, why drug reactions like Stevens-Johnson Syndrome can be linked to immune overactivation, and how genetic testing might one day predict who responds best. You’ll see how immune-related side effects are reported to the FDA, how patients manage long-term treatment, and why some people need to avoid certain supplements while on these drugs. This isn’t a textbook. It’s what people actually deal with when they’re in treatment.
Myasthenia gravis causes muscle weakness that worsens with use and improves with rest. Learn how AChR and MuSK antibodies drive the disease, why immunotherapy like IVIG, rituximab, and efgartigimod are changing treatment, and how thymectomy can lead to remission.
View Details